137 related articles for article (PubMed ID: 6688679)
41. Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
Willett CG; Linggood RM; Leong JC; Miketic LM; Stracher MA; Skates SJ; Kushner DC
J Clin Oncol; 1988 May; 6(5):819-24. PubMed ID: 3367187
[TBL] [Abstract][Full Text] [Related]
42. [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
Kanaev SV; Kolygin BA; Malinin AP; Chikrizov SI
Vopr Onkol; 1986; 32(9):53-6. PubMed ID: 3765524
[TBL] [Abstract][Full Text] [Related]
43. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
[TBL] [Abstract][Full Text] [Related]
44. Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Ryoo MC; Kagan AR; Wollin M; Nussbaum H; Chan PY; Hintz BL; Rao AR; McMahon J
Am J Clin Oncol; 1987 Jun; 10(3):185-93. PubMed ID: 3591736
[TBL] [Abstract][Full Text] [Related]
45. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
[TBL] [Abstract][Full Text] [Related]
46. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
47. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
48. Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Bayle-Weisgerber C; Lemercier N; Teillet F; Asselain B; Gout M; Schweisguth O
Cancer; 1984 Jul; 54(2):215-22. PubMed ID: 6547073
[TBL] [Abstract][Full Text] [Related]
49. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
[TBL] [Abstract][Full Text] [Related]
50. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
[TBL] [Abstract][Full Text] [Related]
51. Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
Bonadonna G; Valagussa P; Santoro A
Cancer Surv; 1985; 4(2):439-58. PubMed ID: 2430700
[TBL] [Abstract][Full Text] [Related]
52. Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?
Mauch P; Hellman S
Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):947-9. PubMed ID: 7204134
[No Abstract] [Full Text] [Related]
53. Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-up.
Olver IN; Wolf MM; Cruickshank D; Worotniuk V; Ding JC; Cooper IA; Matthews JP
Cancer; 1988 Jul; 62(2):233-9. PubMed ID: 3383124
[TBL] [Abstract][Full Text] [Related]
54. [Treatment of Hodgkin's disease including the staging laparotomy].
Yosida T; Nakanisi J; Kobayasi S; Ohtake S; Ito K; Nakamura S; Hattori K; Saito Y; Tanimoto K
Rinsho Ketsueki; 1984 Jun; 25(6):827-34. PubMed ID: 6548266
[No Abstract] [Full Text] [Related]
55. The management of Hodgkin's disease in relapse after primary radiation therapy.
Hoppe RT
Eur J Cancer; 1992; 28A(11):1920-2. PubMed ID: 1389536
[TBL] [Abstract][Full Text] [Related]
56. [Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
Hansz J; Burchardt K; Komarnicki M; Trepińska E; Psuja P
Pol Arch Med Wewn; 1984 Dec; 72(6):293-8. PubMed ID: 6549512
[No Abstract] [Full Text] [Related]
57. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
[No Abstract] [Full Text] [Related]
58. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
van den Berg H; Stuve W; Behrendt H
Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
[TBL] [Abstract][Full Text] [Related]
59. Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
North LB; Fuller LM; Sullivan-Halley JA; Hagemeister FB
Radiology; 1987 Sep; 164(3):599-602. PubMed ID: 3112862
[TBL] [Abstract][Full Text] [Related]
60. Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
Henkelmann GC; Hagemeister FB; Fuller LM
J Clin Oncol; 1988 Aug; 6(8):1293-302. PubMed ID: 3411342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
